Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Frost & Sullivan presents the “Global Gene Therapy Crdmo Technology Innovation Leadership Award” to PackGene Biotech Inc.
1+ day, 1+ hour ago (0+ words) ...
SANA: Hypoimmune cell therapy for diabetes nears trials; in vivo CAR T data expected in 2027
2+ day, 10+ hour ago (88+ words) TradingView Two major platforms are advancing: a hypoimmune cell therapy for type 1 diabetes nearing clinical trials, and an in vivo CAR T program targeting cancer, with first human data expected in 2027. Manufacturing scale-up, regulatory alignment, and site training are progressing,…...
Northway opens €61M Vilnius plant built for personalized medicine - European Biotechnology Magazine
2+ day, 14+ hour ago (352+ words) CDMO company Northway Biotech has opened a €61 million cell therapy and personalized medicine center in Vilnius that is being qualified for GMP manufacturing, and the company says it expects a manufacturing authorization from Lithuania's State Medicines Control Agency within six…...
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
2+ day, 10+ hour ago (221+ words) Ginkgo plans to build the automation hardware and control software for ESCALATOR, a continuous-flow, autonomous manufacturing system designed to produce and quality-release RNA drug products at patient scale Ginkgo’s Role: Making Twenty Instruments Behave as One System Ginkgo is building…...
Philadelphia's Minaris Partners With Bionova Scientific to Expand Plasmid DNA Supply for Cell and Gene Therapy
2+ day, 18+ hour ago (76+ words) BioBuzz Minaris, the cell and gene therapy CDMO headquartered at Philadelphia’s Navy Yard, and Bionova Scientific LLC, an Asahi Kasei company with facilities in Fremont, California, and The Woodlands, Texas, announced on September 9, 2026 a strategic partnership to expand access to…...
BBIO: Multiple late-stage therapies targeting rare genetic diseases set for US launches by 2027
3+ day, 13+ hour ago (79+ words) TradingView BBIO: Multiple late-stage therapies targeting rare genetic diseases set for US launches by 2027 BridgeBio advances a broad pipeline of genetic disease therapies, with three approved medicines and several late-stage candidates targeting multi-billion dollar markets. Attruby leads with strong performance,…...
Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius
4+ day, 16+ hour ago (568+ words) The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine. Northway Biotech has opened a €61 million cell therapy and personalized medicine facility in Vilnius, Lithuania, expanding its CDMO capabilities in advanced therapies....
SANA: Advancing gene-modified islet and in vivo CAR T therapies, with key trials and data expected soon
4+ day, 14+ hour ago (88+ words) TradingView SANA: Advancing gene-modified islet and in vivo CAR T therapies, with key trials and data expected soon The session highlighted progress toward a one-time, gene-modified islet therapy for type 1 diabetes, with IND filing and phase I/II trials expected…...
ProBioGen Grants Transgene Additional License for AGE1.CR.pIX Cell Line
4+ day, 9+ hour ago (302+ words) ProBioGen and Transgene report that they broadened the scope of their existing collaboration to include an additional license agreement for ProBioGen’s suspension AGE1.CR.plXR cell line which is designed to boost Transgene’s manufacturing capabilities with this specialized production technology. ProBioGen…...
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
4+ day, 10+ hour ago (657+ words) BioSpace Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform U.S. Patent No. 12,692,476 Has an Expected Expiration Date of June 9, 2043 CARLSBAD, Calif.--(BUSINESS WIRE)--$LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage…...